Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor.

[1]  M. Schorn,et al.  Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors. , 2014, ACS chemical biology.

[2]  C. Zhan,et al.  Fundamental reaction pathway and free energy profile for inhibition of proteasome by Epoxomicin. , 2012, Journal of the American Chemical Society.

[3]  Andrew T. Fenley,et al.  The Carmaphycins: New Proteasome Inhibitors Exhibiting an α,β‐Epoxyketone Warhead from a Marine Cyanobacterium , 2012, ChemBioChem.

[4]  Ricarda Schwab,et al.  Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity , 2012, Cell.

[5]  H. Overkleeft,et al.  Proteasome inhibitors: an expanding army attacking a unique target. , 2012, Chemistry & biology.

[6]  M. Groll,et al.  Analysing properties of proteasome inhibitors using kinetic and X-ray crystallographic studies. , 2012, Methods in molecular biology.

[7]  S. Molineaux,et al.  Molecular Pathways: Targeting Proteasomal Protein Degradation in Cancer , 2011, Clinical Cancer Research.

[8]  P. Pevzner,et al.  Cytotoxic veraguamides, alkynyl bromide-containing cyclic depsipeptides from the marine cyanobacterium cf. Oscillatoria margaritifera. , 2011, Journal of natural products.

[9]  T. Muchamuel,et al.  Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events , 2011, Clinical Cancer Research.

[10]  W. Gerwick,et al.  Two cytotoxic stereoisomers of malyngamide C, 8-epi-malyngamide C and 8-O-acetyl-8-epi-malyngamide C, from the marine cyanobacterium Lyngbya majuscula. , 2010, Phytochemistry.

[11]  W. Gerwick,et al.  Evolved Diversification of a Modular Natural Product Pathway: Apratoxins F and G, Two Cytotoxic Cyclic Depsipeptides from a Palmyra Collection of Lyngbya bouillonii , 2010, Chembiochem : a European journal of chemical biology.

[12]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[13]  M. Groll,et al.  Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition. , 2009, Journal of medicinal chemistry.

[14]  Donald G Truhlar,et al.  Performance of SM6, SM8, and SMD on the SAMPL1 test set for the prediction of small-molecule solvation free energies. , 2009, The journal of physical chemistry. B.

[15]  Keiji Tanaka,et al.  Molecular mechanisms of proteasome assembly , 2009, Nature Reviews Molecular Cell Biology.

[16]  Edward G Hohenstein,et al.  Assessment of the Performance of the M05-2X and M06-2X Exchange-Correlation Functionals for Noncovalent Interactions in Biomolecules. , 2008, Journal of chemical theory and computation.

[17]  B. Moore,et al.  Advances in and applications of proteasome inhibitors. , 2008, Current opinion in chemical biology.

[18]  Bradley S Moore,et al.  Mutasynthesis of fluorosalinosporamide, a potent and reversible inhibitor of the proteasome. , 2008, Angewandte Chemie.

[19]  R. Huber,et al.  A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism , 2008, Nature.

[20]  D. Truhlar,et al.  The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .

[21]  M. Groll,et al.  20S proteasome and its inhibitors: crystallographic knowledge for drug development. , 2007, Chemical reviews.

[22]  A. Goldberg.  Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy. , 2007, Biochemical Society transactions.

[23]  Robert Huber,et al.  Purification, crystallization, and X-ray analysis of the yeast 20S proteasome. , 2005, Methods in enzymology.

[24]  K. Hultzsch.  Catalytic asymmetric hydroamination of non-activated olefins. , 2005, Organic & biomolecular chemistry.

[25]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[26]  M. Beller,et al.  Catalytic Markovnikov and anti-Markovnikov functionalization of alkenes and alkynes: recent developments and trends. , 2004, Angewandte Chemie.

[27]  J. Hartwig,et al.  Broensted Acid-Catalyzed Intramolecular Hydroamination of Protected Alkenylamines. Synthesis of Pyrrolidines and Piperidines. , 2002 .

[28]  J. Hartwig,et al.  Brønsted acid-catalyzed intramolecular hydroamination of protected alkenylamines. Synthesis of pyrrolidines and piperidines. , 2002, Organic letters.

[29]  R. Huber,et al.  Crystal Structure of Epoxomicin:20S Proteasome reveals a molecular basis for selectivity of alpha,beta-Epoxyketone Proteasome Inhibitors , 2000 .

[30]  C. Crews,et al.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[32]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[33]  R. Huber,et al.  Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.

[34]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[35]  Talapady N. Bhat,et al.  Calculation of an OMIT map , 1988 .